held in
Thursday,
On
The agenda for the annual general meeting was as follows:
- The chairman's report on the activities of the Company in the past financial year
- Adoption of the annual report for 2023
- Covering of loss pursuant to the adopted annual report for 2023
- Election of members of the Board of Directors
- Election of auditor
- Proposals from the Board of Directors
- Proposed resolution regarding the level of remuneration to the Board of Directors for the financial year 2024
- Proposals from shareholders
- Miscellaneous
Lawyer
The chairman of the meeting announced that the general meeting had been duly convened, as the notice of the annual general meeting was given on
The maximum number of votes on the general meeting was 166,627,989 votes and a total of 3,550,000 votes were represented divided between 3,500,000 votes by post (written votes) and 50,000 votes by those shareholders in physical attendance.
The chairman concluded that the general meeting formed a quorum with respect to the agenda.
Re 1
The report was duly noted by the general meeting.
Re 2
The Board of Directors proposed that the annual report for 2023 is adopted.
The annual report for 2023 was adopted unanimously.
Re 3
The Board of Directors proposed that the loss for the financial year 2023 of tDKK 62,260 is carried forward to the next financial year in accordance with the adopted annual report.
This proposal, that the loss for the financial year 2023 of tDKK 62,260 is carried forward to the next financial year in accordance with the annual report for 2023, was adopted unanimously.
Re 4
The Board of Directors proposed re-election of all existing board members:
Carsten Trads Christian Carlsen Jeppe Krog Rasmussen
Re 5
The Board of Directors proposed re-election of
Re 6a)
The Board of Directors proposed the following level of remuneration to the Board of Directors for the financial year 2024:
Position | Annual fee (DKK) |
Chairman | 240,000 |
Vice chairman | 180,000 |
Board member | 120,000 |
The proposed remuneration is in addition to any economic benefit to the board members pursuant to existing warrant programs.
The proposed resolution was adopted unanimously.
Re 7
No proposals from shareholders were received.
Re 8
There were no questions or comments under this item on the agenda.
There was no other business to be attended.
------
The meeting was closed.
Chairman of the meeting:
__________________________
https://news.cision.com/dancann-pharma/r/dancann-pharma-a-s--minutes-of-annual-general-meeting,c3991912
https://mb.cision.com/Main/19875/3991912/2834133.pdf
(c) 2024 Cision. All rights reserved., source